危重症患者气管插管诱导剂:随机对照试验的系统评价与网络Meta分析
该系统评价与网络Meta分析纳入21项RCT、6031例在ICU、急诊科、手术室和院前接受气管插管的危重症成人和儿童患者,比较不同镇静诱导剂。与依托咪酯相比,氯胺酮插管期间血流动力学不稳定更多(RR 1.31;95%CI 1.15-1.48;中等确定性);氯胺酮-丙泊酚较依托咪酯(RR 0.44;95%CI 0.27-0.72;低确定性)和氯胺酮(RR 0.34;95%CI 0.21-0.56;低确定性)可能减少血流动力学不稳定。与依托咪酯相比,氯胺酮可能减少插管后启动持续输注血管加压药(RR 0.80;95%CI 0.50-1.28;低确定性)。依托咪酯较其他药物增加肾上腺抑制。作者认为这些竞争效应的临床重要性仍不确定,需进一步随机试验。
要点
- 与依托咪酯相比,氯胺酮插管期间血流动力学不稳定更多(RR 1.31;95%CI 1.15-1.48;中等确定性)。
- 氯胺酮-丙泊酚较依托咪酯可能减少插管期间血流动力学不稳定(RR 0.44;95%CI 0.27-0.72;低确定性)。
- 氯胺酮-丙泊酚较氯胺酮可能减少插管期间血流动力学不稳定(RR 0.34;95%CI 0.21-0.56;低确定性)。
- 与依托咪酯相比,氯胺酮可能减少插管后启动持续输注血管加压药(RR 0.80;95%CI 0.50-1.28;低确定性,未达统计学显著)。
- 依托咪酯较其他药物增加肾上腺抑制。
适用人群与场景
- 在急诊科、ICU、手术室和院前环境中接受气管插管的危重症成人或儿童。
- 纳入比较≥2种镇静诱导剂的随机对照试验。
研究设计与关键结果
- 系统评价与网络Meta分析纳入21项RCT、6031例患者,覆盖ICU、急诊科、手术室和院前环境。
- 与依托咪酯相比,氯胺酮插管期间血流动力学不稳定更多(RR 1.31;95%CI 1.15-1.48;中等确定性)。
- 氯胺酮-丙泊酚较依托咪酯可能减少插管期间血流动力学不稳定(RR 0.44;95%CI 0.27-0.72;低确定性)。
- 氯胺酮-丙泊酚较氯胺酮可能减少插管期间血流动力学不稳定(RR 0.34;95%CI 0.21-0.56;低确定性)。
- 与依托咪酯相比,氯胺酮可能减少插管后启动持续输注血管加压药(RR 0.80;95%CI 0.50-1.28;低确定性)。
- 依托咪酯较其他药物增加肾上腺抑制。
证据类型、等级与局限
- 证据类型:随机对照试验的系统评价与网络Meta分析,采用GRADE方法评定证据确定性。
- 与依托咪酯相比氯胺酮插管期间血流动力学不稳定的估计为中等确定性。
- 氯胺酮-丙泊酚减少血流动力学不稳定的估计为低确定性。
- 氯胺酮减少插管后启动持续输注血管加压药的估计为低确定性。
- 作者认为现有证据过于有限和不确定,不足以支持确定性结论,需要进一步随机试验。
对床旁实践的改变
- 选择插管诱导剂时需权衡插管期间血流动力学不稳定与插管后启动持续输注血管加压药的需求:与依托咪酯相比,氯胺酮插管期间血流动力学不稳定更多(RR 1.31;中等确定性),但可能减少插管后启动持续输注血管加压药(RR 0.80;低确定性)。
- 依托咪酯较其他药物增加肾上腺抑制。
- 氯胺酮-丙泊酚可能减少插管期间血流动力学不稳定(较依托咪酯RR 0.44,较氯胺酮RR 0.34;低确定性),但作者认为证据过于有限和不确定,不足以支持确定性结论。
指南或共识出处
- International Prospective Register of Systematic Reviews;注册号:CRD42024600739;网址:https://www.crd.york.ac.uk/prospero/
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Tracheal intubation is a common yet high-risk procedure in critically ill patients, with as many as one-half experiencing peri-intubation adverse outcomes.
RESEARCH QUESTION: What is the comparative effectiveness and safety of various sedative agents used for endotracheal intubation of critically ill patients in the emergency department (ED), ICU, operating room, and prehospital setting?
STUDY DESIGN AND METHODS: We conducted a network meta-analysis and systematic review of randomized controlled trials. We searched MEDLINE, EMBASE, PubMed, Cochrane, and trial registries from inception through December 10, 2025, for randomized controlled trials (RCTs) comparing ≥ 2 sedative agents in critically ill adults or children undergoing endotracheal intubation. Outcomes of interest were hemodynamic instability during intubation, hypoxemia, cardiac arrest, mortality, ICU and hospital length of stay, vasopressor use, adrenal insufficiency, and first-pass success. Reviewers screened, extracted data, and assessed risk of bias using the Cochrane RoB 2 tool independently and in duplicate. We performed frequentist random-effects model network meta-analysis and used the Grading of Recommendations, Assessment, Development, and Evaluation approach to rate certainty in estimates.
RESULTS: We included 21 RCTs enrolling 6,031 patients across ICU, ED, operating room, and prehospital settings. Compared with etomidate, more hemodynamic instability exists during intubation with ketamine (relative risk [RR], 1.31; 95% CI, 1.15-1.48; moderate certainty). Ketamine-propofol may decrease hemodynamic instability during intubation compared with etomidate (RR, 0.44; 95% CI, 0.27-0.72; low certainty) and ketamine (RR, 0.34; 95% CI, 0.21-0.56; low certainty). Compared with etomidate, ketamine may decrease the need for the initiation of postintubation continuous infusion vasopressors (RR, 0.80; 95% CI, 0.50-1.28; low certainty). Etomidate caused increased adrenal suppression compared with other agents.
INTERPRETATION: Our results show that when considering sedation agents for endotracheal intubation of critically ill patients, etomidate probably causes less hemodynamic instability during intubation when compared with ketamine. However, etomidate may increase the need for the initiation of postintubation continuous infusion vasopressors when compared with ketamine and increases adrenal suppression. The clinical importance of these competing effects remains uncertain. Ketamine-propofol may decrease hemodynamic instability during intubation when compared with etomidate and ketamine, although the available evidence is too limited and uncertain to support firm conclusions, and further randomized trials are needed.
CLINICAL TRIAL REGISTRATION: International Prospective Register of Systematic Reviews; No.: CRD42024600739; URL: https://www.crd.york.ac.uk/prospero/.
参考来源
- McDougall G, Forestell B, Sadeghirad B, et al. Induction Agents for Tracheal Intubation of Critically Ill Patients: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Chest. 2026. PMID: 42612901. doi:10.1016/j.chest.2026.07.5239
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。